DARREN BATES: Open Payments
NPI 1710666532 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 28 payments from 7 companies in 2025. Trend: 2023 $532 · 2024 $1,170 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $219 |
| Ardelyx, Inc. | 5 | $83 |
| Gilead Sciences, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: IBSRELA, QULIPTA, RINVOQ, MAVYRET, DUPIXENT, LINZESS, VRAYLAR, MOUNJARO.
Industry payments across NC — which companies pay providers there.
